Who invested in Syntaxin?
Syntaxin's investors include Abingworth, SR One, Johnson & Johnson Development Corporation (JJDC), EQT life science and Seventure Partners, and 3 more on record.
United Kingdom · Series C startup
3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$71Mraised across 3 rounds since 2005, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by fiercebiotech.com
Reported by syntaxin.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Syntaxin's investors include Abingworth, SR One, Johnson & Johnson Development Corporation (JJDC), EQT life science and Seventure Partners, and 3 more on record.
Syntaxin has raised $71M across 3 rounds since 2005.
Syntaxin's most recent round was a Series C of $29M in Nov 2010.
Syntaxin's largest round on record is $32M (Series B), in Oct 2007.
Syntaxin's first round on record, in Nov 2005, was backed by Abingworth.
Syntaxin's latest named round is a Series C, in Nov 2010.
Syntaxin is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.